Results 31 to 40 of about 211,324 (159)
Journal of Diabetes, Volume 14, Issue 5, Page 315-333, May 2022., 2022 Highlights This consensus document identifies challenging areas and strategic recommendations for the effective management of cardiorenal complications in type 2 diabetes mellitus in the Middle East and North Africa and Africa. There is a need for optimum glycemic control, early identification of cardiorenal complications, along with risk management ...
Alper Sonmez +12 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 5, Page 345-355, May 2022., 2022 Highlights Provide key information on the correlation between kidney disease measures and arterial stiffness by evaluating urine albumin‐creatinine ratio and estimated glomerular filtration rate simultaneously in a large sample with type 2 diabetes. Improving management of arterial stiffness, before reaching the chronic kidney disease stage, should ...
Chen Xu +14 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 236-246, April 2022., 2022 Highlights Diabetic kidney disease is a progressive disease with the pathology of glomerular damage and loss of podocytes. Sodium glucose cotransporter 2 inhibitors (SGLT2i) can be expected to decrease the amount of podocyte excretion. Male patients receiving SGLT2i have better diabetic kidney disease‐related parameters and podocyturia levels. Abstract
Emre Durcan +13 more
wiley +1 more source
Journal of Diabetes, Volume 14, Issue 4, Page 291-297, April 2022., 2022 Highlights C3c deposition in the kidney was associated with worse renal outcomes and was an independent predictor for ESRD in DKD patients with T2DM. C3c deposition in the kidney might be a novel biomarker indicating DKD progression in T2DM. Abstract Background Although extensive efforts have been paid to identify reliable predictors for renal outcomes
Meng‐Rui Li +6 more
wiley +1 more source
MMC celebrating 6 years of experience and expansion 庆祝MMC六年的经验和壮大
, 2022 Journal of Diabetes, Volume 14, Issue 5, Page 356-357, May 2022.
Itamar Raz
wiley +1 more source
中西医结合护理, 2021 Objective To understand the incidence of hypoglycemia in patients with diabetic nephropathy(DN)or non-DN during hemodialysis and explore whether there is a difference in the degree of fear of hypoglycemia and depression between DN and non-DN patients on ...
JIA Wanning (贾婉宁) +4 more
doaj +1 more source
Zhongguo shiyan zhenduanxue, 2023 糖尿病肾病(diabetic kidney disease,DKD)是糖尿病代谢异常引发的肾小球硬化症，是其全身微血管病的组成部分，也是导致终末期肾脏病的重要原因。据第10版《全球糖尿病地图》统计，2021年中国糖尿病患者数量可达1.4亿，预计2045年将超过1.74亿[1]。Zhang等人[2]的荟萃分析表明，在中国，21.8%的2型糖尿病患者合并有糖尿病肾病。微量白蛋白尿的出现，被认为是早期糖尿病肾病的标志，但近些年来发现部分2型糖尿病合并肾功能衰退患者无异常蛋白尿，这为糖尿病肾病的诊治带来困难 ...
梁爽, 郭贺, 李洪军
doaj
Research progress of risk factors and nursing of diabetic nephropathy (糖尿病肾病患者危险因素及护理进展)
中西医结合护理, 2023 Diabetic nephropathy is one of the common microvascular complications in patients with diabetes, which is difficult to treat clinically, and is also a common cause of end-stage renal failure.
LI Shanshan (李珊珊) +1 more
doaj +1 more source
, 2012 目的观察益气养阴、活血祛瘀中药联合西药治疗早期糖尿病肾病的疗效。方法将早期糖尿病肾病患者46例随机分为2组,治疗组23例,采用基础治疗方案加用益气养阴、活血祛瘀中药治疗,对照组23例仅采用基础方案治疗,2组均治疗8周。结果治疗组总有效率为87%,对照组总有效率为70%,2组比较有显著性差异 ...
陈敏, 俞翔
core
早期糖尿病肾病血清β2-微球蛋白、尿微量白蛋白测定的临床意义 [PDF]
, 2018 目的:回顾性分析β2-微球蛋白、尿微量白蛋白表达及诊断情况与糖尿病肾病病情发展情况相关性,从而明确二者在早期糖尿病肾病中的诊断价值。方法:选取2016年5月-2017年10月在笔者所在医院治疗的糖尿病患者100例,将该100例患者按临床诊断分为临床无肾病组、早期肾病组、临床肾病组。选取40例来笔者所在医院做健康体检的正常个体作为对照组。对糖尿病肾病患者及正常个体血清β2-微球蛋白、尿微量白蛋白进行检测并进行对比分析。结果:血液检测中,对照组血清β2-微球蛋白水平为（2.24±1.08）mg/L ...
廖蕴惠, 赵军
core +1 more source